/Investor DB

Highbury Holdings — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Curve Healthcurvehealth.comin𝕏Seed · Oct 2020 · $6M

Curve Health operates a telemedicine platform combined with data analytics and health information exchange that connects bedside providers with remote clinicians.

Digital HealthHealthtechMedical DevicesSaaSMiami, US

Timothy Peck(Director)inMatthew Michela(CEO & Board Member)inCharlene Frizzera(Director)Stephen Bruso(Director)

Co-investorsAlumni VenturesKapor CapitalLightspeed Venture PartnersRosecliff VenturesWestway CapitalCorrelation Ventures+6 more

Octant Biooctant.bioin𝕏Series A · May 2020 · $30M

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US

Sri Kosuri(Founder)inRamsey Homsany(Founder)inRobert Andrade(Executive Officer, Director, Promoter)Maurice J. Costantini(Executive Officer, Director, Promoter)

Co-investorsAndreessen Horowitz+ND Capital8VCCarbon SiliconCatalio Capital Management, LPExplorer Investments+10 more

Satellite Biosatellite.bioSeed · Nov 2020 · $19M

Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.

BiotechHealthtechCambridge, US

Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)

BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)

Co-investorsAlumni VenturesaMoonCatalio Capital Management, LPLightspeed Venture PartnersPolaris PartnersS32

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.